SLC7A11 and cancer: Moreover, 3′- UTR has been revealed to be effective RNA-based therapy tools for treating cardiac diseases irrespective of its cognate protein [50], the findings in this study suggested that mutated SLC7A11, GPX4 and CP 3′-UTRs may be effective RNA-based therapeutic targets for DOXIC in cancer patients.